ACTIVE

PHARMACIE D'AYWAILLE

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result-15,8 k €-305,0 %over 1 year
Gross margin169,9 k €-20,8 %over 1 year
Equity18,9 k €-45,6 %over 1 year
Workforce1,2 ETP-40,0 %over 1 year

Identity

Source · BCE/KBO

PHARMACIE D'AYWAILLE is a Private limited company incorporated in 2016. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Aywaille. It employs on average 1,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0666.985.559
Incorporation
06/12/2016
Legal form
Private limited company
Registered office
Rue Nicolas Lambercy 6
4920 Aywaille · WallonieSee on map
Contributed capital
37 200,00 €
Latest accounts
31/12/2025
Average workforce
1,2 ETP
Joint committees (1)
  • 313
Contacts
1 public detail availableLog in to view
Signals
Positive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 9 filings

Trend over 9 financial years

20252024202320222021
Income statement
Gross margin169,9 k €214,6 k €269,5 k €123,1 k €150 k €
EBITDA61,7 k €89,8 k €106,7 k €36,6 k €74,5 k €
Operating result-1,2 k €26,3 k €43,7 k €-6,4 k €29,7 k €
Net result-15,8 k €7,7 k €23,9 k €-12 k €21,7 k €
Balance sheet
Equity18,9 k €34,6 k €26,9 k €-15,5 k €-3,5 k €
Total assets612,2 k €689,6 k €750,1 k €438,8 k €484,4 k €
Cash86,2 k €80,5 k €98,5 k €24,2 k €21,2 k €
Debts592,8 k €654,4 k €723,1 k €454,3 k €487,8 k €
Other
Workforce1,2 ETP2,0 ETP2,9 ETP2,1 ETP1,8 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 0 € and 100 k€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 5 ended

Active mandates

IDEAL PHARMA

Director · since 24 mai 2026 · 1037.092.425

Represented by Isabelle Detrait

Active
Isabelle DETRAIT

Director · since 13 juin 2023 · until 24 mai 2026

Active
Geneviève LALOUX

Administrator - manager · since 06 décembre 2016 · until 24 mai 2026

Active

Ended mandates

Isabelle DETRAIT

Director · since 13 juin 2023

Ended
Isabelle Detrait

Director · since 31 mai 2023

Ended
MARIE LALOUX GENEVIEVE

Administrator - manager · since 06 décembre 2016

Ended
Genevieve Laloux

Manager · since 05 décembre 2016

Ended

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date09/06/202628/08/202530/08/202405/06/202307/07/202220/07/2021
General meeting05/06/202606/06/202507/06/202402/06/202303/06/202204/06/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 9 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202505/06/202609/06/2026FrenchPDF
Abridged model31/12/202406/06/202528/08/2025FrenchPDF
Abridged model31/12/202307/06/202430/08/2024FrenchPDF
Abridged model31/12/202202/06/202305/06/2023FrenchPDF
Abridged model31/12/202103/06/202207/07/2022FrenchPDF
Abridged model31/12/202004/06/202120/07/2021FrenchPDF
Abridged model31/12/201905/06/202027/08/2020FrenchPDF
Abridged model31/12/201807/06/201927/08/2019FrenchPDF
Abridged model31/12/201730/03/201823/08/2018FrenchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 0 € and 100 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 5 ended

Active mandates

IDEAL PHARMA

Director · since 24 mai 2026 · 1037.092.425

Represented by Isabelle Detrait

Active
Isabelle DETRAIT

Director · since 13 juin 2023 · until 24 mai 2026

Active
Geneviève LALOUX

Administrator - manager · since 06 décembre 2016 · until 24 mai 2026

Active

Ended mandates

Isabelle DETRAIT

Director · since 13 juin 2023

Ended
Isabelle Detrait

Director · since 31 mai 2023

Ended
MARIE LALOUX GENEVIEVE

Administrator - manager · since 06 décembre 2016

Ended
Genevieve Laloux

Manager · since 05 décembre 2016

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates18/06/2026
    DEMISSIONS, NOMINATIONS
    PDF
  • Mandates15/06/2023
    MODIFICATION FORME JURIDIQUE - DENOMINATION - DEMISSIONS, NOMINATIONS
    PDF
  • Other08/12/2016
    RUBRIQUE CONSTITUTION (NOUVELLE PERSONNE MORALE, OUVERTURE SUCCURSALE, ETC...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025-15,8 k €↓
  2. 2024
    Annual accounts 20247,7 k €↓
  3. 2024
    Name changeD'AYWAILLE PHARMACIE
  4. 2023
    Annual accounts 202323,9 k €↑
  5. 2023
    Name changePHARMACIE D'AYWAILLE
  6. 2022
    Annual accounts 2022-12 k €↓
  7. 2021
    Annual accounts 202121,7 k €↑
  8. 2021
    Name changePHARMACIE LALOUX
  9. 2020
    Annual accounts 202018,3 k €↑
  10. 2019
    Annual accounts 2019-21,3 k €↑
  11. 2018
    Annual accounts 2018-25,6 k €↓
  12. 2017
    Annual accounts 2017-15,1 k €
  13. 06/12/2016
    IncorporationPrivate limited company